Conflicts of Interest- Disclosures
Conflicts of Interest- Disclosures
Full List to go thru
https://medicine.yale.edu/eugene_shapiro-2.profile?source=news
Dr. Shapiro has received royalty payments from UptoDate; has been an expert witness in malpractice cases involving Lyme disease; and is an unpaid board member of the American Lyme Disease Foundation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657585/
~~
Studies that report unexpected positive blood cultures for Lyme borrelia - are they valid?
Dr. Shapiro has received royalty payments from UptoDate; has been an expert witness in malpractice cases involving Lyme disease; and is an unpaid board member of the American Lyme Disease Foundation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657585/
~~
A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease.
Dr Shapiro has received royalty payments from UptoDate; has been an expert witness in malpractice cases involving Lyme disease; and is an unpaid board member of the American Lyme Disease Foundation.
https://www.ncbi.nlm.nih.gov/pubmed?term=27914746
~~
2016- Fatigue in patients with erythema migrans.
Dr. Shapiro has received royalty payments from UptoDate; has been an expert witness in malpractice cases involving Lyme disease; and is an unpaid board member of the American Lyme Disease Foundation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061607/
~~
2007- A Critical Appraisal of Chronic Lyme Disease
Dr. Shapiro reports serving as an expert witness in
medical-malpractice cases related to Lyme disease, reviewing
claims of disability related to Lyme disease for Metropolitan Life
Insurance Company, and receiving speaker’s fees from Merck and
Sanofi-Aventis.
https://www.researchgate.net/publication/5931063_A_Critical_Appraisal_of_Chronic_Lyme_Disease
~~
Unorthodox alternative therapies marketed to treat Lyme disease.
2015- E. D. S. – Expert witness in legal proceedings related to Lyme disease. Unpaid board member of the American Lyme Disease Foundation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490322/
~~
2015- Repeat or persistent Lyme disease: persistence, recrudescence or reinfection with Borrelia Burgdorferi?
The author receives royalties from UptoDate.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311275/
~~
Dr. Shapiro or an immediate family member serves as a board member, owner, officer, or committee member of the American Board of Pediatrics, Sub-board on Infectious Diseases, and the American Lyme Disease Foundation.
Lyme disease and the orthopaedic implications of lyme arthritis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656475/
~~
Dr. Shapiro reports providing medical-record review for law firms for malpractice cases regarding Lyme disease. No other potential conflict of interest relevant to this article was reported.
Lyme Disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492124/
~~
EDS is a board member of the American Lyme Disease Foundation, for which no compensation is received. He has reviewed medical records for the Metropolitan Life Insurance Company and has provided medicolegal testimony.
2011- Antiscience and ethical concerns associated with advocacy of Lyme disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489928/
~~
E. D. S. – Expert witness in legal proceedings related to Lyme disease. Unpaid board member of the American Lyme Disease Foundation.
2015- Unorthodox Alternative Therapies Marketed to Treat Lyme Disease
https://academic.oup.com/cid/article/60/12/1776/2462643
~~
Dr. Eugene Shapiro reports having served as an expert witness in medical malpractice cases related to Lyme disease. He has reviewed claims of disability related to Lyme disease for Metropolitan Life Insurance Company.
Let's tackle the testing
https://www.bmj.com/rapid-response/2011/11/01/lyme-wars-critique-misses-mark
~~
EDS is a board member of the American Lyme Disease Foundation, for which no compensation is received, and has received compensation from UpToDate for reviewing medical records for the Metropolitan Life Insurance Company and providing medicolegal testi- mony.
The Reply
https://www.amjmed.com/article/S0002-9343(13)00878-4/abstract
Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437837/
~~
Borrelia burgdorferi (Lyme disease).
AUTHOR DISCLOSURE
Dr. Shapiro has disclosed that this article was made possible, in part, by support from Clinical and Translational Science Award grants UL1 TR000142 and KL2 TR000140 from the National Center for Research Resources and the National Center for Advancing Translational Science, components of the National Institutes of Health, and National Institutes of Health Roadmap for Medical Research. This commentary does contain a discussion of an unapproved/investigative use of a commercial product/device.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029759/
~~
ED Shapiro received speaker honoraria from Eastern Maine Medical Center, received research support from NIH/NIAID/NDDK;
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429663/
Impact of a clinical interventions bundle on uptake of HPV vaccine at an OB/GYN clinic.
Declarations of interest- None.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314176/
~~
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470506/
~~
Conflict of interest statement: D.M.W. has previously received an investigator-initiated research grant from Pfizer and consulting fees from Pfizer, Merck, GSK, and Affinivax. L.S. and R.J.T. have an ownership interest in Sage Analytica, a research consultancy with government, nongovernment, and pharmaceutical industry clients, including an investigator-initiated research grant from Pfizer (completed in 2013).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321019/
~~
Declaration of Conflicting Interests
Dr. Niccolai has received consulting fees from Merck.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573381/
~~
Update on persistent symptoms associated with Lyme disease.
Conflicts of interest
None.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417349/
~~
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071110/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121731/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106242/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127692/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773171/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652387/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639321/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630739/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390844/
Results of a Targeted Screening Program for Congenital Cytomegalovirus Infection in Infants Who Fail Newborn Hearing Screening.
ED Shapiro received speaker honoraria from Eastern Maine Medical Center, received research support from NIH/NIAID/NDDK;
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429663/
Missed opportunities for HPV immunization among young adult women.
The views expressed herein are those of the authors and do not necessarily represent the official views of the National Institutes of Health.
The authors report no conflict of interest.
Presented at the 31st International Papillomavirus Conference, Cape Town, South Africa, February 2017.
https://www.ncbi.nlm.nih.gov/pubmed?term=29223597
~~
Shared Decision-Making with Parents of Acutely Ill Children: A Narrative Review.
Conflicts of Interest: None of the authors have potential conflicts of interest, including relevant financial interests, activities, relationships, or affiliations.
https://www.ncbi.nlm.nih.gov/pubmed?term=28723588
~~
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497863/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272647/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304943/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483512/
No Access To...
Am J Med. 2019 Feb;132(2):136-137. doi: 10.1016/j.amjmed.2018.08.012. Epub 2018 Aug 23.
Borrelia miyamotoi: An Emerging Tick-Borne Pathogen.
Wormser GP1, Shapiro ED2, Fish D3.
1 Division of Infectious Diseases, New York Medical College,Valhalla. Electronic address: g_wormser@nymc.edu.
2 Department of Pediatrics,Yale School of Medicine,Yale University, New Haven, Conn; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University New Haven, Conn.
3 Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University New Haven, Conn.
PMID: 30144406 DOI: 10.1016/j.amjmed.2018.08.012
https://www.ncbi.nlm.nih.gov/pubmed?term=30144406
~~
JAMA. 2018 Dec 18;320(23):2482-2483. doi: 10.1001/jama.2018.17207.
Controversies About Lyme Disease-Reply.
Shapiro ED1, Wormser GP2.
1 Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
2 Division of Infectious Diseases, New York Medical College, Valhalla.
https://jamanetwork.com/journals/jama/article-abstract/2718789
~~
Pediatrics. 2018 Dec;142(6). pii: e20181879. doi: 10.1542/peds.2018-1879. Epub 2018 Nov 13.
~~
Am J Med. 2017 Jul;130(7):771-772. doi: 10.1016/j.amjmed.2017.01.030. Epub 2017 Feb 16.
False and Misleading Information About Lyme Disease.
Shapiro ED1, Baker PJ2, Wormser GP3.
https://www.ncbi.nlm.nih.gov/pubmed?term=28216447
~~
Risk Stratification of Febrile Infants ≤60 Days Old Without Routine Lumbar Puncture.
Aronson PL1,2, Wang ME3, Shapiro ED4,5, Shah SS6,7, DePorre AG8, McCulloh RJ8,9, Pruitt CM10, Desai S7, Nigrovic LE11, Marble RD12, Leazer RC13, Rooholamini SN14, Sartori LF15, Balamuth F16,17, Woll C4,2, Neuman MI11; Febrile Young Infant Research Collaborative.
https://www.ncbi.nlm.nih.gov/pubmed?term=30425130
~~
Diagn Microbiol Infect Dis. 2018 Nov;92(3):183-188. doi: 10.1016/j.diagmicrobio.2018.06.007. Epub 2018 Jun 18.
Critical analysis of a doxycycline treatment trial of rhesus macaques infected with Borrelia burgdorferi.
Wormser GP1, O'Connell S2, Pachner AR3, Schwartz I4, Shapiro ED5, Stanek G6, Strle F7.
https://www.ncbi.nlm.nih.gov/pubmed?term=30017315
~~
Clin Infect Dis. 2018 Oct 13. doi: 10.1093/cid/ciy875. [Epub ahead of print]
Differences in the impact of pneumococcal serotype replacement in individuals with and without underlying medical conditions.
Weinberger DM1, Warren JL2, Dalby T3, Shapiro ED1,4, Valentiner-Branth P5, Slotved HC3, Harboe ZB3,6.
https://www.ncbi.nlm.nih.gov/pubmed?term=30321313
~~
Clin Infect Dis. 2018 Oct 12. doi: 10.1093/cid/ciy873. [Epub ahead of print]
Prevention of Pneumococcal Infections in Adults using Conjugate Vaccines: No Easy Answers.
Weinberger DM1, Shapiro ED1,2.
https://www.ncbi.nlm.nih.gov/pubmed?term=30312380
~~
J Pediatr. 2018 Sep;200:210-217.e1. doi: 10.1016/j.jpeds.2018.04.033. Epub 2018 May 18.
Epidemiology and Etiology of Invasive Bacterial Infection in Infants ≤60 Days Old Treated in Emergency Departments.
Woll C1, Neuman MI2, Pruitt CM3, Wang ME4, Shapiro ED5, Shah SS6, McCulloh RJ7, Nigrovic LE2, Desai S8, DePorre AG9, Leazer RC10, Marble RD11, Balamuth F12, Feldman EA13, Sartori LF14, Browning WL15, Aronson PL16; Febrile Young Infant Research Collaborative.
https://www.ncbi.nlm.nih.gov/pubmed?term=29784512
~~
Diagn Microbiol Infect Dis. 2017 May;88(1):108-109. doi: 10.1016/j.diagmicrobio.2017.01.018. Epub 2017 Feb 8.
Response letter to Drs. Halperin and Greenberg.
Wormser GP1, Strle F2, Shapiro ED3, Dattwyler RJ4, Auwaerter PG5.
JAMA. 2018 Aug 21;320(7):635-636. doi: 10.1001/jama.2018.10974.
https://www.ncbi.nlm.nih.gov/pubmed?term=28238387
~~
Lancet Infect Dis. 2017 Mar;17(3):246-248. doi: 10.1016/S1473-3099(16)30551-5. Epub 2016 Dec 20.
Prophylaxis with topical azithromycin against Lyme borreliosis.
Shapiro ED1, Wormser GP2.
https://www.ncbi.nlm.nih.gov/pubmed?term=28007427
~~
Lyme Disease in 2018: What Is New (and What Is Not).
Shapiro ED1,2, Wormser GP3.
https://www.ncbi.nlm.nih.gov/pubmed?term=30073279
~~
https://www.ncbi.nlm.nih.gov/pubmed?term=30030367
https://www.ncbi.nlm.nih.gov/pubmed?term=28838740
https://www.ncbi.nlm.nih.gov/pubmed?term=28250095
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367961/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928503/
https://www.ncbi.nlm.nih.gov/pubmed?term=26094814
https://www.ncbi.nlm.nih.gov/pubmed?term=25617604
https://www.ncbi.nlm.nih.gov/pubmed?term=26625446
https://www.ncbi.nlm.nih.gov/pubmed?term=25035398
https://www.ncbi.nlm.nih.gov/pubmed?term=24462014
https://www.ncbi.nlm.nih.gov/pubmed?term=18419530
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600214/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234453/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2096633/
https://www.ncbi.nlm.nih.gov/pubmed?term=17041854
https://www.ncbi.nlm.nih.gov/pubmed?term=16968847
https://www.ncbi.nlm.nih.gov/pubmed?term=16651306
https://www.ncbi.nlm.nih.gov/pubmed?term=15970784
https://www.ncbi.nlm.nih.gov/pubmed?term=15655771
https://www.ncbi.nlm.nih.gov/pubmed?term=15689581
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1560727/
https://www.ncbi.nlm.nih.gov/pubmed?term=14970064
https://www.ncbi.nlm.nih.gov/pubmed?term=14872178
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1494683/
https://www.ncbi.nlm.nih.gov/pubmed?term=14688562
https://www.ncbi.nlm.nih.gov/pubmed?term=12897313
https://www.ncbi.nlm.nih.gov/pubmed?term=12544414
JAMA Intern Med. 2017 Mar 1;177(3):303-304. doi: 10.1001/jamainternmed.2016.8289.
Developing Better Pneumococcal Vaccines for Adults.
Weinberger DM1, Harboe ZB2, Shapiro ED3.
1 Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.
2 Statens Serum Institut, Copenhagen, Denmark3Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
3 Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut4Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
Conflict of Interest Disclosures: Dr Weinberger reported receiving research funding from an investigator-initiated grant from Pfizer to Yale University as well as consulting fees from Pfizer, GSK, Merck, and Affinivax. Dr Harboe has reported receiving travel grants from Pfizer. No other disclosures were reported. None of the authors has current or planned consulting relationships or other financial arrangements with vaccine manufacturers, and none of the authors has any financial stake in the vaccination strategy discussed.
Funding/Support: This work was supported by grants R56AI110449 and R01AI123208 from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (Drs Weinberger and Shapiro), grant P30AG021342 from the NIH National Institute of Aging (Dr Weinberger), as Scholar at the Yale Claude D. Pepper Older Americans Independence Center, grant OPP1114733 from the Bill and Melinda Gates Foundation, and in part by grant KL2TR001862 from the Clinical and Translational Science Award Program and grant UL1TR001863 from the National Center for Advancing Translational Sciences at the NIH and the NIH Roadmap for Medical Research (Drs Shapiro and Weinberger).
Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568894/
~~
Pneumococcal conjugate vaccines for adults- Reasons for optimism and for caution
D.M.W. has received consulting fees from Merck (the manufacturer of PPV23) and receives salary support from an investigator-initiated research grant from Pfizer (the manufacturer of PCV13) to Yale University. E.D.S. has nothing to disclose.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896592/
~~
~~
Lyme Disease
Eugene D. Shapiro1 and Michael A. Gerber2
1Departments of Pediatrics and of Epidemiology and Public Health and the Children’s Clinical Research Center, Yale University School of Medicine, New Haven, and 2Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut
Received 5 October 1999; revised 12 January 2000; electronically pub- lished 14 September 2000.
Financial support: National Institutes of Health (RR-06022, AI-01703). E.D.S. has received research support and consulted for Pasteur Me ́rieux Connaught Laboratories and has given lectures that have been supported by Glaxo-Wellcome and by SmithKline Beecham, companies that manu- facture products to prevent or treat Lyme disease.
Reprints or correspondence: Dr. Eugene D. Shapiro, Dept. of Pediatrics, Yale University School of Medicine, 333 Cedar St., New Haven, CT 06520- 8064 (Eugene.Shapiro@Yale.edu).
Clinical Infectious Diseases 2000;31:533–42
~~
Grant
Project Number: 1K24AI001703-01
Contact PI / Project Leader: SHAPIRO, EUGENE DAVID
Title: THE EFFECTIVENESS OF VACCINES IN CLINICAL PRACTICE
Awardee Organization: YALE UNIVERSITY
QUOTE- "In future years he plans to conduct a case- control study of the effectiveness of the recently-licensed Lyme vaccine and, eventually, a case-control study of the effectiveness of conjugate pneumococcal vaccine (which is expected to be licensed within the next 12-24 months) in children."
~~
Effectiveness Over Time of Varicella Vaccine
QUOTE- "Drs Shapiro and Gershon served as consultants at a 1-day meeting on vaccine cost- effectiveness sponsored by Merck & Co."
Original Contribution
February 18, 2004
Effectiveness Over Time of Varicella Vaccine
Marietta Vázquez, MD; Philip S. LaRussa, MD; Anne A. Gershon, MD; Linda M. Niccolai, PhD; Catherine E. Muehlenbein, MPH; Sharon P. Steinberg; Eugene D. Shapiro, MD
See pdf of article
https://jamanetwork.com/journals/jama/fullarticle/198218